chr3-39265456-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001337.4(CX3CR1):āc.1054T>Cā(p.Leu352=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,609,916 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.011 ( 33 hom., cov: 32)
Exomes š: 0.0011 ( 29 hom. )
Consequence
CX3CR1
NM_001337.4 synonymous
NM_001337.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.32
Genes affected
CX3CR1 (HGNC:2558): (C-X3-C motif chemokine receptor 1) Fractalkine is a transmembrane protein and chemokine involved in the adhesion and migration of leukocytes. The protein encoded by this gene is a receptor for fractalkine. The encoded protein also is a coreceptor for HIV-1, and some variations in this gene lead to increased susceptibility to HIV-1 infection and rapid progression to AIDS. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-39265456-A-G is Benign according to our data. Variant chr3-39265456-A-G is described in ClinVar as [Benign]. Clinvar id is 783371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.32 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0105 (1605/152310) while in subpopulation AFR AF= 0.0365 (1516/41552). AF 95% confidence interval is 0.035. There are 33 homozygotes in gnomad4. There are 753 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 33 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CX3CR1 | NM_001337.4 | c.1054T>C | p.Leu352= | synonymous_variant | 2/2 | ENST00000399220.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CX3CR1 | ENST00000399220.3 | c.1054T>C | p.Leu352= | synonymous_variant | 2/2 | 1 | NM_001337.4 | P1 | |
CX3CR1 | ENST00000358309.3 | c.1150T>C | p.Leu384= | synonymous_variant | 2/2 | 2 | |||
CX3CR1 | ENST00000541347.5 | c.1054T>C | p.Leu352= | synonymous_variant | 2/2 | 4 | P1 | ||
CX3CR1 | ENST00000542107.5 | c.1054T>C | p.Leu352= | synonymous_variant | 2/2 | 4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1608AN: 152190Hom.: 33 Cov.: 32
GnomAD3 genomes
AF:
AC:
1608
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00259 AC: 641AN: 247290Hom.: 8 AF XY: 0.00199 AC XY: 267AN XY: 134132
GnomAD3 exomes
AF:
AC:
641
AN:
247290
Hom.:
AF XY:
AC XY:
267
AN XY:
134132
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00113 AC: 1652AN: 1457606Hom.: 29 Cov.: 31 AF XY: 0.000943 AC XY: 683AN XY: 724526
GnomAD4 exome
AF:
AC:
1652
AN:
1457606
Hom.:
Cov.:
31
AF XY:
AC XY:
683
AN XY:
724526
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0105 AC: 1605AN: 152310Hom.: 33 Cov.: 32 AF XY: 0.0101 AC XY: 753AN XY: 74492
GnomAD4 genome
AF:
AC:
1605
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
753
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at